AVIR: the cashflow

MyFinsight

For the quarter ending 2025-09-30, AVIR had -$10,377K decrease in cash & cash equivalents over the period.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Total research and development expense	92,088	-
Total general and administrative	17,730	-
Stock based compensation	16,135	-
Other segment items	-12,471	-
Net loss	-42,049	-71,433
Stock-based compensation expense	4,517	11,618
Depreciation and amortization expense	104	208
Accretion of premium and discounts on marketable securities	1,075	3,061
Prepaid expenses and other current assets	938	-1,743
Other assets	1,081	4,197
Accounts payable	-5,329	4,386
Accrued expenses and other liabilities	5,524	-2,602
Operating lease liabilities	-48	-95
Net cash used in operating activities	-40,375	-63,433
Purchases of marketable securities	14,780	223,368
Sales and maturities of marketable securities	56,083	324,266
Net cash provided by investing activities	41,303	100,898
Proceeds from issuance of common stock under espp	63	138
Proceeds from issuance of common stock upon exercise of stock options	58	-
Repurchase of common stock	11,426	14,093
Issuance of restricted stock units	0	485
Net cash (used in) provided by financing activities	-11,305	-14,440
Net increase in cash and cash equivalents	-10,377	23,025
Cash and cash equivalents at beginning of period	64,696	-
Cash and cash equivalents at end of period	77,344	-

Unit: Thousand (K) dollars